Peer-Reviewed Publications - Page 2 of 5 - Carterra

Peer-Reviewed Publication

A next-generation Fab library platform directly yielding drug-like antibodies with high affinity, diversity, and developability

Peer-Reviewed Publication

Direct selection of functional fluorescent-protein antibody fusions by yeast display

Peer-Reviewed Publication

TitrationAnalysis: a tool for high throughput binding kinetics data analysis for multiple label-free platforms

Peer-Reviewed Publication

Cryptic-site-specific antibodies to the SARS-CoV-2 receptor binding domain can retain functional binding affinity to spike variants

Peer-Reviewed Publication

Antibodies: Isolation and Characterization of Neutralizing Monoclonal Antibodies from a Large Panel of Murine Antibodies against RBDoftheSARS-CoV-2 Spike Protein

Peer-Reviewed Publication

Widespread monoclonal IgE antibody convergence to an immunodominant, proanaphylactic Ara h 2 epitope in peanut allergy

Peer-Reviewed Publication

Science: LY-CoV555, a Rapidly Isolated Potent Neutralizing Antibody, Provides Protection in a Non-Human Primate Model of SARS-CoV-2 Infection

Peer-Reviewed Publication

Absci achieves a breakthrough in AI drug creation

Peer-Reviewed Publication

Healthy humans can be a source of antibodies countering COVID-19

Peer-Reviewed Publication

Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage libraries

Peer-Reviewed Publication

High-Throughput Surface Plasmon Resonance Biosensors for Identifying Diverse Therapeutic Monoclonal Antibodies

Peer-Reviewed Publication

Drug-like antibodies with high affinity, diversity and developability directly from next-generation antibody libraries

Peer-Reviewed Publication

Accelerated antibody discovery targeting the SARS-CoV-2 spike protein for COVID-19 therapeutic potential

Peer-Reviewed Publication

Presence and Strength of Binding of IgM, IgG and IgA Antibodies Against SARS-CoV-2 During COVID-19 Infection

1
2
3